Overview of Healthcare Financial Challenges
The US healthcare system continues to face considerable financial strain, although there are pockets of opportunity emerging across various segments. Industry EBITDA as a percentage of national health expenditures (NHE) fell from 11.2 percent in 2019 to 8.9 percent in 2024, representing a significant decline in overall profitability and operational efficiency.
Projected EBITDA Decline Through 2027
In 2027, the financial picture is expected to worsen slightly, with industry EBITDA as a percentage of NHE projected to drop to 8.7 percent. This downward trajectory reflects systemic challenges including regulatory changes, reimbursement pressures, and shifting market dynamics that are fundamentally reshaping the healthcare landscape.
Impact on Payers and Providers
Payer Challenges and Enrollment Declines
Payers and providers have borne the brunt of the financial decline to date and will continue to feel substantial pressure in the immediate future. Payers are facing enrollment declines in Medicaid and Affordable Care Act (ACA) plans because of regulatory changes and policy shifts. The expiration of enhanced subsidies has accelerated member disenrollment, creating revenue headwinds for health insurance companies.
The One Big Beautiful Bill Act (OBBBA) has introduced policy-driven changes in Medicaid business that are further complicating the payer landscape. These regulatory modifications are forcing health plans to reassess their market strategies and operational models.
Provider Financial Pressures
Meanwhile, healthcare providers could experience a significant increase in uncompensated care and loss of reimbursement revenue. As patients lose insurance coverage through Medicaid and ACA disenrollment, hospitals and physician groups face mounting bad debt and charity care obligations that strain already thin margins.
Strategic Responses to Financial Pressure
Near-Term Tactical Actions
Looking ahead to 2028 and 2029, industry analysts anticipate stronger financial results underpinned by healthcare players’ actions to buttress their financial position. Organizations will likely move tactically to address pricing and cost structures, implementing operational improvements and efficiency initiatives.
Long-Term Strategic Shifts
Strategic initiatives will focus on reallocating resources to growing market segments and pursuing business portfolio optimization through mergers and acquisitions (M&A) and divestitures. Healthcare organizations are expected to divest non-core assets while acquiring capabilities in high-growth areas like technology-enabled care delivery and specialty services.
Emerging Growth Opportunities
High-Growth Healthcare Segments
While the overall near-term outlook is somber, significant opportunities exist in several parts of the industry. Some segments of healthcare are continuing to grow rapidly, including health services and technology (HST), supported by advances in artificial intelligence and digital health platforms.
Specialty pharmacy represents another bright spot, driven by increased utilization of high-cost specialty medications and biologics. The specialty pharmacy market continues to expand as new treatments for complex conditions reach the market.
Ambulatory care in the provider space is experiencing robust growth as healthcare delivery shifts from expensive hospital settings to lower-cost outpatient facilities. Ambulatory surgery centers and urgent care clinics are capturing market share from traditional acute care providers.
Payer Opportunities in Group Insurance
For payers, group insurance is emerging as a critical growth area as some members may be able to obtain insurance from their employers after disenrolling from ACA plans and Medicaid. This shift creates opportunities for commercial payers to capture market share in the employer-sponsored insurance segment.
Geographic and Demographic Considerations
In the acute care segment, attention to trends in working-age populations and demographic mix in geographies will be key to identifying and capturing value pools. Markets with favorable demographics and strong employment trends offer the best opportunities for acute care providers.
Segment-Specific Outlook
EBITDA Growth Projections
Industry estimates indicate that overall healthcare EBITDA will grow annually at 5 percent in 2024–27, reflecting the challenging near-term environment. However, growth is expected to accelerate to 10 percent annually in 2027–29 as strategic initiatives take hold and market conditions stabilize.
Certain segments are expected to increase more slowly in 2026–27 due to ACA disenrollment given expiration of enhanced subsidies and to policy-driven changes in Medicaid business under OBBBA. Other areas, such as HST and specialty pharmacy, are likely to grow steadily throughout the 2024–29 period, demonstrating resilience amid industry headwinds.
Path Forward for Healthcare Leaders
Healthcare leaders must rethink traditional business models, improve operational performance, and embrace technology innovations to remain competitive in this evolving landscape. Organizations that successfully navigate the transition will be well positioned to lead the next chapter of US healthcare delivery and financing.
Strategic priorities should include investing in digital health capabilities, optimizing care delivery networks, and pursuing value-based care arrangements that align incentives across the healthcare ecosystem. Leaders must also focus on enhancing patient experience while managing costs and improving clinical outcomes.
Discover the latest payers’ news updates with a single click. Follow DistilINFO HealthPlan and stay ahead with updates. Join our community today!
